PGP and Alzheimer disease: Multiple studies analyzing P-gp function using the PET tracer [11C]verapamil have shown decreased activity in multiple brain regions in patients with AD compared to age-matched controls [7, 68], which in turn can lead to accumulation and aggregation of Aβ peptides.